We thank Huixun Jia and Xiaodong Sun for their perspective on our study.1 The goals of this first-in-human trial were to identify safe doses of RGX-314 and an optimised protocol for advanced studies.

The Laser Vision Correction Center of New Jersey is the first practice in New Jersey to offer the Valeda Light Delivery ...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...

Ocular Therapeutix's Axpaxli targets wet AMD with long-acting treatment. Click here to find out why OCUL stock is a Strong ...

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Company will discuss its patented remote monitoring high-resolution retinal imaging system RetinalCam™ and associated ...

As one of the cheapest new options among the best gaming TVs, TCL's QM7 is the definition of value. It leverages a 120Hz ...

Looking ahead to 2025, Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies.

Delicious it might be, but healthy it is not. According to Medical News Today, foods that are high cholesterol have been ...

Right now, the IND-enabling studies are made to test the safety, tolerability, vector biodistribution, transgene expression, ...

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular ...

Genocea Biosciences (NASDAQ:GNCA – Get Free Report) and Kodiak Sciences (NASDAQ:KOD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...